10th Conference of the Central European Division eV of the International Isotope Society
…, O Post, L Hofstede, M van den Heuvel…
文献索引：Wiegerinck, Peter; Post, Olaf; Hofstede, Leontine; Heuvel, Marcel van den Journal of Labelled Compounds and Radiopharmaceuticals, 2002 , vol. 45, # 13 p. 1169 - 1171
BIIL 284 BS is a new LTB4 receptor antagonist developed as a novel anti-inflammatory principle for several chronic inflammatory conditions. It is a prodrug, which is metabolised to the active metabolite BIIL 260. BIIL 260 has a high affinity to the LTB4-receptor with a Ki value of 1.7 nM on human neutrophilic granulocytes. For the characterization of BIIL 260 in its interaction with the LTB4 receptor the preparation of the tritium labelled isotopomer with ...
